NeoGenomics Beats Investor Suit Over Growth Driver Claims
Cancer diagnostics company NeoGenomics Inc. no longer faces a proposed investor class action alleging it mischaracterized its growth drivers, including by failing to disclose that a rainmaking unit potentially ran afoul...To view the full article, register now.
Already a subscriber? Click here to view full article